A Phase 1 Dose-Escalation Study to Determine the Safety of TH-302 in Combination with Sunitinib in Patients with Advanced Renal Cell Carcinoma Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The main purpose of the study is to find out the highest and safest levels of two drugs when they are given together.
Description
The main purpose of the study is to find out the highest and safest levels of two drugs when they are given together.
Details
| Condition | Kidney,Pancreatic Cancers |
|---|---|
| Age | 18years - 100years |
| Clinical Study Identifier | TX2870 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.